Inhibition of histone deacetylases sensitizes EGF receptor‐TK inhibitor‐resistant non‐small‐cell lung cancer cells to erlotinib in vitro and in vivo

BACKGROUND AND PURPOSE: Intrinsic and/or acquired resistance of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) commonly occurs in patients with non‐small‐cell lung cancer (NSCLC). Here, we developed a combined therapy of histone deacetylase inhibition by a novel HDAC inhib...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Pharmacol
Hoofdauteurs: Yu, Weiwei, Lu, Weiqiang, Chen, Guoliang, Cheng, Feixiong, Su, Hui, Chen, Yihua, Liu, Mingyao, Pang, Xiufeng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Research Papers
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5610149/
https://ncbi.nlm.nih.gov/pubmed/28749535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13961
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items